the aid library

LIST OPTIONS

Filter

714

Dermatological Preparations For The Tropics
recommended

Peter Bakker; Herman Woerdenbag; Vincent Gooskens; Ben Naafs, et al. (2012) C_WHO

A formulary of dermatological preparations and background information on therapeutic choices, production and dispensing. 2nd edition

Download (285)

View PDF (333)

Guidance for the prevention and control of COVID-19 in temporary reception centres in the context of the large numbers of people fleeing Ukraine
recommended

European Centre for Disease Prevention and Control ECDC (2022) C1

This document offers public health guidance for the prevention and control of COVID-19 in reception centres, and other temporary accommodation facilities, in the context of the mass influx of Ukrainian people into the European Union (EU), the European Economic Area (EEA) and the Republic of Moldova.

Download (313)

View PDF (357)

Strengthening the Assessment of Lymphatic Filariasis Transmission and documenting the Achievement of Elimination

World Health Organization WHO (2014) C_WHO

Meeting of the Neglected Tropical Diseases Strategic and Technical Advisory Group’s Monitoring and Evaluation Subgroup on Disease-specific Indicators

External Link

Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection.

Abras A., Ballart C., Fernández-Arévalo A., et al. Clinical Microbiology Reviews (2022) CC

April 2022 Volume 35 Issue 2 e00152-21 Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t... more

Download (1014)

View PDF (1607)

Global report on psoriasis

World Health Organization WHO (2016) C_WHO

Psoriasis, which can involve the skin, nails and joints, is a chronic, painful, disfiguring and disabling noncommunicable disease (NCD) for which there is no cure. It negatively impacts on quality of life. Some of those who suffer from the disease develop chronic, inflammatory arthritis (psoriatic a... more

External Link

Disease diagnosis in primary care in Uganda

Martin Kayitale Mbonye, Sarah M Burnett, Robert Colebunders, et al. (2014) CC

BMC Family Practice201415:165, DOI: 10.1186/1471-2296-15-165 Open Access

Download (258)

View PDF (301)

Assessing Facility Capacity, Costs of Care, and Patient Perspectives. Health Service Provision in Kenya

Institute for Health Metrics and Evaluation (IHME) (2014) C1

Download (290)

View PDF (262)

Access to Essential Supplies

The Independent Panel (2021) CC

Background paper 7 The Independent Panel for Pandemic Preparedness and Response May 2021

Download (455)

View PDF (747)

WHO Country Cooperation Strategy Kenya: medium-term support strategy 2014 - 2019

World Health Organization (WHO), Kenya Country Office (2014) C_WHO

Download (473)

View PDF (900)

Outbreak of plague in Madagascar, 2017 (9 October 2017)

European Centre for Disease Prevention and Control (2017) C1

Download (384)

View PDF (318)

The future of WHO Covid-19 response operations in Africa in 2022
recommended

World Health Organization WHO, Regional Office of Africa (2022) C_WHO

The African Region has been experiencing unprecedented health challenges due to the Coronavirus disease 2019 (COVID-19) pandemic, which have compounded the already difficult task the Region was facing in moving towards universal health coverage (UHC) attainment.

Download (221)

View PDF (344)

Mpox Continental Preparedness and Response Plan for Africa
recommended

World Health Organisation (WHO) (2024) C_WHO

On August 13, 2024, the Africa CDC declared the mpox outbreak a Public Health Emergency of Continental Security (PHECS). The following day, the WHO declared it a Public Health Emergency of International Concern (PHEIC). A coordinated, continent-wide response is essential, co-led by the African Union... more

Download (586)

View PDF (1441)

Uganda: Integrated Community Case Management of Childhood Malaria, Pneumonia and Diarrhoea - Implementation Guidelines

World Health Organization WHO; UNICEF; Ministry of Health Uganda (2010) C_WHO

Download (646)

View PDF (1351)

WHO recommendations on newborn health: Guidelines approved by the WHO Guidelines Review Committee
recommended

World Health Organization (WHO) (2017) C_WHO

Updated May 2017
This document is meant to respond to the questions:
■ What health interventions should be the newborn and young infants < 2 months of age receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?

Download (2364)

View PDF (1849)

Regional Guidelines for the Management of Severe Falciparum Malaria in Large Hospitals

World Health Organization (WHO), Regional Office for South-East Asia (2006) C_WHO

hese are two parallel guidelines, one for small hospitals and another one for large hospitals. In view of heavy burden of malaria and prevalence of drug resistant falciparum malaria in the South-East Asia Region, the guidelines were developed for use by medical personnel who treat severe malaria pat... more

Download (646)

View PDF (1815)

Kenya - Floods - Emergency Plan of Action DREF operation n° MDRK036 Final Report

International Federation of Red Cross And Red Crescent Societies (2016) C1

Download (213)

View PDF (256)

Guidelines for COVID-19 testing and quarantine of air travellers - Addendum to the Aviation Health Safety Protocol

European Centre for Disease Prevention and Control ECDC (2020) CC

This joint ECDC-European Union Aviation Safety Agency (EASA) document aims to support Member States in determining a coordinated approach to reduce the risks related to the movement of people by air within and between the EU/EEA countries and the UK in the context of the COVID-19 pandemic, noting th... more

Download (416)

View PDF (630)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (303)

View PDF (541)

WHO AFRO Outbreaks and Other Emergencies, Week 13: 25 - 31 March 2019; Data as reported by 17:00; 31 March 2019

World Health Organization WHO (2019) C_WHO

Response to the tropical cyclone in southern Africa Ebola virus disease outbreak in the Democratic Republic of the Congo Meningitis outbreak in Togo Lassa fever outbreak in Liberia.

Dermatological Preparations For The Tropics recommended

Guidance for the prevention and control of COVID-19 in temporary reception centres in the context of the large numbers of people fleeing Ukraine recommended

The future of WHO Covid-19 response operations in Africa in 2022 recommended

Mpox Continental Preparedness and Response Plan for Africa recommended

WHO recommendations on newborn health: Guidelines approved by the WHO Guidelines Review Committee recommended

Dermatological Preparations For The Tropics
recommended

Guidance for the prevention and control of COVID-19 in temporary reception centres in the context of the large numbers of people fleeing Ukraine
recommended

The future of WHO Covid-19 response operations in Africa in 2022
recommended

Mpox Continental Preparedness and Response Plan for Africa
recommended

WHO recommendations on newborn health: Guidelines approved by the WHO Guidelines Review Committee
recommended